Cargando…

Tea Compounds and the Gut Microbiome: Findings from Trials and Mechanistic Studies

In recent years, the gut microbiome has become a focal point of interest with growing recognition that a well-balanced gut microbiota composition is highly relevant to an individual’s health status and well-being. Its profile can be modulated by a number of dietary factors, although few publications...

Descripción completa

Detalles Bibliográficos
Autores principales: Bond, Timothy, Derbyshire, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835862/
https://www.ncbi.nlm.nih.gov/pubmed/31623411
http://dx.doi.org/10.3390/nu11102364
_version_ 1783466773306146816
author Bond, Timothy
Derbyshire, Emma
author_facet Bond, Timothy
Derbyshire, Emma
author_sort Bond, Timothy
collection PubMed
description In recent years, the gut microbiome has become a focal point of interest with growing recognition that a well-balanced gut microbiota composition is highly relevant to an individual’s health status and well-being. Its profile can be modulated by a number of dietary factors, although few publications have focused on the effects of what we drink. The present review performed a systematic review of trials and mechanistic studies examining the effects of tea consumption, its associated compounds and their effects on the gut microbiome. Registered articles were searched up to 10th September 2019, in the PubMed and Cochrane library databases along with references of original articles. Human trials were graded using the Jadad scale to assess quality. Altogether 24 publications were included in the main review—six were human trials and 18 mechanistic studies. Of these, the largest body of evidence related to green tea with up to 1000 mL daily (4–5 cups) reported to increase proportions of Bifidobacterium. Mechanistic studies also show promise suggesting that black, oolong, Pu-erh and Fuzhuan teas (microbially fermented ‘dark tea’) can modulate microbial diversity and the ratio of Firmicutes to Bacteroidetes. These findings appear to support the hypothesis that tea ingestion could favourably regulate the profile of the gut microbiome and help to offset dysbiosis triggered by obesity or high-fat diets. Further well-designed human trials are now required to build on provisional findings.
format Online
Article
Text
id pubmed-6835862
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68358622019-11-25 Tea Compounds and the Gut Microbiome: Findings from Trials and Mechanistic Studies Bond, Timothy Derbyshire, Emma Nutrients Communication In recent years, the gut microbiome has become a focal point of interest with growing recognition that a well-balanced gut microbiota composition is highly relevant to an individual’s health status and well-being. Its profile can be modulated by a number of dietary factors, although few publications have focused on the effects of what we drink. The present review performed a systematic review of trials and mechanistic studies examining the effects of tea consumption, its associated compounds and their effects on the gut microbiome. Registered articles were searched up to 10th September 2019, in the PubMed and Cochrane library databases along with references of original articles. Human trials were graded using the Jadad scale to assess quality. Altogether 24 publications were included in the main review—six were human trials and 18 mechanistic studies. Of these, the largest body of evidence related to green tea with up to 1000 mL daily (4–5 cups) reported to increase proportions of Bifidobacterium. Mechanistic studies also show promise suggesting that black, oolong, Pu-erh and Fuzhuan teas (microbially fermented ‘dark tea’) can modulate microbial diversity and the ratio of Firmicutes to Bacteroidetes. These findings appear to support the hypothesis that tea ingestion could favourably regulate the profile of the gut microbiome and help to offset dysbiosis triggered by obesity or high-fat diets. Further well-designed human trials are now required to build on provisional findings. MDPI 2019-10-03 /pmc/articles/PMC6835862/ /pubmed/31623411 http://dx.doi.org/10.3390/nu11102364 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Bond, Timothy
Derbyshire, Emma
Tea Compounds and the Gut Microbiome: Findings from Trials and Mechanistic Studies
title Tea Compounds and the Gut Microbiome: Findings from Trials and Mechanistic Studies
title_full Tea Compounds and the Gut Microbiome: Findings from Trials and Mechanistic Studies
title_fullStr Tea Compounds and the Gut Microbiome: Findings from Trials and Mechanistic Studies
title_full_unstemmed Tea Compounds and the Gut Microbiome: Findings from Trials and Mechanistic Studies
title_short Tea Compounds and the Gut Microbiome: Findings from Trials and Mechanistic Studies
title_sort tea compounds and the gut microbiome: findings from trials and mechanistic studies
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835862/
https://www.ncbi.nlm.nih.gov/pubmed/31623411
http://dx.doi.org/10.3390/nu11102364
work_keys_str_mv AT bondtimothy teacompoundsandthegutmicrobiomefindingsfromtrialsandmechanisticstudies
AT derbyshireemma teacompoundsandthegutmicrobiomefindingsfromtrialsandmechanisticstudies